OraSure OTC HIV Test To Enter Phase II Trials By Summer
This article was originally published in The Tan Sheet
Executive Summary
HIV test kit manufacturer OraSure Technologies should be required to conduct actual-use studies as part of Phase III trial commitments, according to an FDA advisory panel